Target wise and pound foolish: A simple technique to evaluate the trade-off between clinical benefit and economic burden of monoclonal antibodies

Matthew Brennan, Timothy Brown, Kristian Koller, Monali Vasekar, Peter Cygan, Ayesha Ali, Jeffrey Sivik, Michael Glantz

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Target wise and pound foolish: A simple technique to evaluate the trade-off between clinical benefit and economic burden of monoclonal antibodies'. Together they form a unique fingerprint.

Medicine & Life Sciences